Skadden Reps Valeant In $3.2B Biovail Merger
Canada's Biovail Corp. agreed Monday to merge with California-based Valeant Pharmaceuticals International Inc. to form a new pharmaceutical giant under the Valeant name in a stock-and-cash deal worth more than $3.2...To view the full article, register now.
Already a subscriber? Click here to view full article